Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-03-04
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Locomotor Training (Walking Therapy) Post Stroke
NCT00715299
Cognitive & Motor Training After Stroke For Everyday Walking Restoration
NCT01160653
Strength Training and Stroke
NCT00629005
Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation
NCT06637839
Enhancing Physical Therapy Best Practice for Improving Walking After Stroke
NCT04238260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard
The standard arm consists of strength, endurance and flexibility exercises 2 times per week for 12 weeks. Will also receive a physical activity behavioral intervention.
Strength training
weight lifting to increase muscle strength
Endurance training
treadmill walking to increase endurance
Flexibility training
stretches to improve flexibility
Physical activity behavioral intervention
Intervention to encourage participants to be more physically active
Standard-plus
The standard-plus arm consists of strength, endurance and flexibility exercises plus task specific timing and coordination exercises to improve gait 2 times per week for 12 weeks. Will also receive a physical activity behavioral intervention.
Strength training
weight lifting to increase muscle strength
Endurance training
treadmill walking to increase endurance
Flexibility training
stretches to improve flexibility
Physical activity behavioral intervention
Intervention to encourage participants to be more physically active
Task Specific timing and coordination training
stepping and walking patterns to improve timing and coordination of gait
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strength training
weight lifting to increase muscle strength
Endurance training
treadmill walking to increase endurance
Flexibility training
stretches to improve flexibility
Physical activity behavioral intervention
Intervention to encourage participants to be more physically active
Task Specific timing and coordination training
stepping and walking patterns to improve timing and coordination of gait
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ambulatory without an assistive device or the assistance of another person
* Usual 4 meter gait speed \> 0.60 m/s and \< 1.2 m/s
* Physician clearance to participate in a moderate intensity exercise program
* Not meeting physical activity recommendations defined as reporting less than 150 minutes of moderate intensity activity per week in the past month.
Exclusion Criteria
* back pain that is present on most days of the weeks and interferes with walking and - activities of daily living or back pain that increases with walking
* refuse to walk on a treadmill
* plans to move out of the area in the next 5 years
* dyspnea at rest or during activities of daily living or use supplemental oxygen (CHF, COPD)
* any acute illness or medical condition that is not stable according to the approving physician
* resting systolic blood pressure ≥ 200 mm Hg or diastolic blood pressure ≥ 100 mm Hg or resting heart rate \> 100 or \< 40 beats per minute
* diagnosed dementia or cognitive impairment defined as modified Mini-Mental State (3MS) examination \<79
* hospitalized in the past 6 months for acute illness or surgery, other than minor surgical procedures
* severe visual impairment f- ixed or fused lower extremity joints such as hip, knee or ankle
* lower extremity strength \<3/5 on manual muscle testing
* lower extremity amputation
* progressive movement disorder such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis or Parkinson's disease
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Rosso
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea L Rosso, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY19110142
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.